We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMK icon
1251
Trustmark
TRMK
$2.75B
$341K 0.01%
+14,781
New +$358K
FMX icon
1252
Fomento Económico Mexicano
FMX
$41.6B
$339K 0.01%
+3,672
New +$353K
OMER icon
1253
Omeros
OMER
$851M
$339K 0.01%
+21,549
New +$298K
CBF
1254
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
$336K 0.01%
10,510
+3,630
+53% +$118K
HMSY
1255
DELISTED
HMS Holdings Corp.
HMSY
$335K 0.01%
+27,134
New +$309K
CUBI icon
1256
Customers Bancorp
CUBI
$2.69B
$334K 0.01%
+12,298
New +$343K
VISN
1257
Vistance Networks Inc
VISN
$2.65B
$333K 0.01%
12,853
-11,907
-48% -$343K
SANM icon
1258
Sanmina
SANM
$9.04B
$333K 0.01%
+16,177
New +$360K
SKX
1259
DELISTED
Skechers
SKX
$333K 0.01%
11,012
-6,514
-37% -$218K
MDC
1260
DELISTED
M.D.C. Holdings, Inc.
MDC
$333K 0.01%
+18,141
New +$344K
CUZ icon
1261
Cousins Properties
CUZ
$5.38B
$332K 0.01%
12,456
+7,619
+158% +$208K
AMG icon
1262
Affiliated Managers Group
AMG
$9.76B
$330K 0.01%
2,064
-1,032
-33% -$177K
WTM icon
1263
White Mountains Insurance
WTM
$5.3B
$329K 0.01%
+453
New +$347K
GMED icon
1264
Globus Medical
GMED
$11B
$328K 0.01%
11,784
+1,997
+20% +$50.1K
PF
1265
DELISTED
Pinnacle Foods, Inc.
PF
$328K 0.01%
7,712
-49,995
-87% -$2.14M
CGNX icon
1266
Cognex
CGNX
$9.73B
$327K 0.01%
+19,346
New +$345K
CXW icon
1267
CoreCivic
CXW
$3B
$327K 0.01%
+12,369
New +$339K
NAVI icon
1268
Navient
NAVI
$834M
$327K 0.01%
28,557
-89,738
-76% -$1.1M
SCHW
1269
Charles Schwab
SCHW
$184B
$327K 0.01%
9,932
+2,281
+30% +$72.2K
XRT icon
1270
State Street SPDR S&P Retail ETF
XRT
$463M
$327K 0.01%
7,564
-1,836
-20% -$82.2K
SLAB icon
1271
Silicon Laboratories
SLAB
$7.16B
$326K 0.01%
+6,701
New +$331K
WABC icon
1272
Westamerica Bancorp
WABC
$1.4B
$326K 0.01%
+6,970
New +$323K
WST icon
1273
West Pharmaceutical
WST
$23.6B
$325K 0.01%
5,388
-7,387
-58% -$444K
CBD
1274
DELISTED
Companhia Brasileira de Distribuicao
CBD
$325K 0.01%
30,885
+8,457
+38% +$110K
CXO
1275
DELISTED
CONCHO RESOURCES INC.
CXO
$325K 0.01%
3,496
-947
-21% -$101K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.